From: The Hippo pathway in disease and therapy: cancer and beyond
Tissue | Protein | Model | Pathology | References |
---|---|---|---|---|
Liver | YAP | Mouse models of inducible active YAP1 in the liver | Increase in liver size | |
Heart | YAP/TAZ | SCA-1-/- human cardiac progenitor cell line | Infarct | [66] |
Cardiac-specific YAP or TAZ knockout mice. Mouse model of inducible active YAP1 in the heart | Loss of function results in impaired neonatal heart regeneration and lethal cardiomyopathy. Activated YAP enhances cardiac regeneration and improves function of ischemic hearts | [67] | ||
YAP | Mouse models of arrhythmogenic cardiomyopathy and human samples | Arrhythmogenic Cardiomyopathy | [47] | |
Mouse models of cardiomyocyte-specific homozygous inactivation of YAP in the postnatal heart | Increased myocyte apoptosis and fibrosis, dilated cardiomyopathy, and premature death. | [68] | ||
Muscle | YAP | Mouse models of inducible active YAP in the skeletal muscle cells | Loss of body weight, gait impairments and kyphosis. Skeletal muscle atrophy. | [69] |
Brain | YAP/TAZ | Rat model of chronic constriction sciatic nerve injury | Neuropathic pain | [70] |
YAP/TAZ | Mammalian cell lines | Alzheimer’s disease | [71] | |
Pancreas | YAP | MST1/2 mutant conditional mouse | Reduction of pancreatic mass, exocrine pancreas disorganization and pancreatitis-like autodigestion | |
Mouse models of inducible active YAP1 in the pancreas | Pancreas increased in total size and acinar cells showed penetrant ductal metaplasia | [64] | ||
Skin | YAP/TAZ | Mice model of wound healing | Wound healing | [72] |
YAP | Mouse models of inducible active YAP1 in the skin | Thickening of the epidermis and increased number of proliferating cells | [64] | |
Eye | YAP/TAZ | Primary human trabecular meshwork cells | Glaucoma | [73] |
Ovary | YAP/TAZ | Mouse model of ovarian fragmentation, ovarian explant and follicle cultures. Primary ovarian insufficiency patients | Primary ovarian insufficiency and polycystic ovarian syndrome | [74] |